No Data
No Data
Labcorp Announces New Strategic Service Offerings Within Precision Oncology Portfolio
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced new strategic service offerings within its...
Laboratory Corp. Is Maintained at Overweight by JP Morgan
Laboratory Corp. Is Maintained at Overweight by JP Morgan
Laboratory Corp. Price Target Cut to $243.00/Share From $261.00 by JP Morgan
Laboratory Corp. Price Target Cut to $243.00/Share From $261.00 by JP Morgan
Komo: Maintaining the Labcorp Holdings (LH.US) rating, adjusted from an increase to an increase in holdings rating, and the target price was adjusted from $261.00 to $243.00.
Komo: Maintaining the Labcorp Holdings (LH.US) rating, adjusted from an increase to an increase in holdings rating, and the target price was adjusted from $261.00 to $243.00.
JP Morgan Maintains Overweight on Labcorp Holdings, Lowers Price Target to $243
JP Morgan analyst Lisa Gill maintains Labcorp Holdings with a Overweight and lowers the price target from $261 to $243.
Labcorp Holdings Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/30/2024 26.23% JP Morgan $261 → $243 Maintains Overweight 04/26/2024 32.47% Truist Securities $270 → $2